MAPT and Alzheimer disease: This is suggestive that Nrf2 is indeed part of a core response of astrocytes to Aß and Tau pathology and, consistent with this, genes induced in GFAP-Nrf2 astrocytes were also found to be enriched in genes upregulated in human AD astrocytes (Fig. 4C, left).